Medications & Supplements/Prescription Drugs

Macleods Pharma Clopidogrel Tablets Recalled Due to Foreign Matter

Agency Publication Date: August 31, 2021

Summary

Macleods Pharma USA Inc. is voluntarily recalling one lot of Clopidogrel (75 mg) tablets, a prescription medication used to prevent blood clots. Approximately 444,000 tablets (distributed in 888 bottles of 500 count) are affected because foreign matter was discovered in the product. No incidents or injuries have been reported to date, but the company is recalling the lot as a precaution to ensure patient safety.

Risk

The presence of foreign matter in oral medication poses a risk of choking, internal irritation, or injury if the tablets are ingested. For patients taking blood-thinning medications, any physical contamination can compromise the safety and quality of their treatment.

What You Should Do

This recall affects Clopidogrel Tablets, USP, 75 mg, sold in 500-count bottles under the Macleods Pharma USA brand with NDC 33342-060-15.
Identify your medication by checking the bottle for lot number BCA82021A and an expiration date of 06/2023.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Macleods Pharma USA Inc. for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for more information.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Clopidogrel Tablets, USP, 75 mg (500-count bottle)

Variants: 75 mg, Tablet

Lot Numbers:

BCA82021A (Exp 06/2023)

NDC:

33342-060-15

Manufactured for Macleods Pharma USA, Inc. by Macleods Pharmaceutical Ltd., Baddi, India.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 88391

Status: Resolved

Manufacturer: Macleods Pharma Usa Inc

Sold By: pharmacies; hospitals

Manufactured In: India, United States

Units Affected: 444,000 tablets / 888 unit packs of 500 count

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Clopidogrel Tablets, USP, 75 mg, sold in 500-count bottles under the Macleods Pharma USA brand with NDC 33342-060-15.

Identify your medication by checking the bottle for lot number BCA82021A and an expiration date of 06/2023.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Macleods Pharma USA Inc. for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for more information.